I am writing with an update about this conference as the new chair.
I am writing with an update about this conference as the new chair.
#Microsky
#glycotime
journals.plos.org/plospathogen...
#Microsky
#glycotime
journals.plos.org/plospathogen...
These new models by @maxgg.bsky.social’s team and AlveoliX are grown from a single person’s stem cells ⤵️ www.crick.ac.uk/news/2026-01...
These new models by @maxgg.bsky.social’s team and AlveoliX are grown from a single person’s stem cells ⤵️ www.crick.ac.uk/news/2026-01...
These new models by @maxgg.bsky.social’s team and AlveoliX are grown from a single person’s stem cells ⤵️ www.crick.ac.uk/news/2026-01...
www.nature.com/naturecareer...
www.nature.com/naturecareer...
www.nature.com/articles/s41...
A thread.
Still plenty of other people to reach before we all wrap up for the holidays, so send family and friends the petition link as an early resolution for a happier New Year! c.org/rstb5XTvns
Still plenty of other people to reach before we all wrap up for the holidays, so send family and friends the petition link as an early resolution for a happier New Year! c.org/rstb5XTvns
1. We've launched a new website for our lab: www.brysonlab.org
2. With some new funding, we are recruiting for new postdocs and graduate students. The projects build upon our previous studies of antigen presentation and phagosome biology and go into new exciting dimensions!
1. We've launched a new website for our lab: www.brysonlab.org
2. With some new funding, we are recruiting for new postdocs and graduate students. The projects build upon our previous studies of antigen presentation and phagosome biology and go into new exciting dimensions!
We’re thrilled to share our new study revealing how the chromatin regulator SP140 preserves protective T cell immunity during #tuberculosis infection by restraining harmful type I IFN responses.
📖 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗽𝗿𝗲𝗽𝗿𝗶𝗻𝘁: shorturl.at/r5jd9
We’re thrilled to share our new study revealing how the chromatin regulator SP140 preserves protective T cell immunity during #tuberculosis infection by restraining harmful type I IFN responses.
📖 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗽𝗿𝗲𝗽𝗿𝗶𝗻𝘁: shorturl.at/r5jd9
Focus: Infectious diseases, host-microbe interactions, vaccines
Special interest: AI methodologies
📅 Deadline: Feb 9, 2026
👥 2-12 years post-PhD
Apply now 📝 research.pasteur.fr/en/call/crea...
#JobOpportunity #Research
Focus: Infectious diseases, host-microbe interactions, vaccines
Special interest: AI methodologies
📅 Deadline: Feb 9, 2026
👥 2-12 years post-PhD
Apply now 📝 research.pasteur.fr/en/call/crea...
#JobOpportunity #Research
journals.plos.org/plospathogen...
journals.plos.org/plospathogen...
@febspress.bsky.social 🔵⚪🔴
We use CRISPRi tools from the @rocklabtb.bsky.social to target essential genes and control smooth to rough transition in M.smegmatis & M.abscessus 🦠🧫👇👇👇
febs.onlinelibrary.wiley.com/doi/10.1002/...
@febspress.bsky.social 🔵⚪🔴
We use CRISPRi tools from the @rocklabtb.bsky.social to target essential genes and control smooth to rough transition in M.smegmatis & M.abscessus 🦠🧫👇👇👇
febs.onlinelibrary.wiley.com/doi/10.1002/...